跳至主要内容
临床试验/NCT06542939
NCT06542939Enrolling By Invitation不适用

Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II)

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 450 人开始时间: 2024年11月11日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
450
试验地点
1
主要终点
Percent of participants achieving BP control, defined as <130/80 mmHg

研究概览

简要总结

The purpose of this study is to test the effectiveness and implementation process of a culturally and contextually tailored telehealth-based community health workers (CHW) led coaching intervention for hypertension control among South Asian patients with co-morbid Diabetes Mellitus type II (DMII) and hypertension. The primary aims are to test the effectiveness of a CHW-led telehealth intervention compared to usual care, and using Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) and Consolidated Framework for Implementation Research (CFIR), examine the reach, adoption, fidelity, and maintenance of the intervention within clinical and community settings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • identified as of South Asian ethnicity
  • at least 21 years of age
  • a diagnosis of diabetes
  • a diagnosis of hypertension
  • an uncontrolled BP reading (>130/80mmHg) in the last 6 months

排除标准

  • under the age of 21
  • Women who are pregnant
  • Type 1 diabetes or diabetes secondary to other conditions (e.g. steroid-induced, pancreatic insufficiency, or chemotherapy-induced)
  • inability to perform unsupervised physical activity

结局指标

主要结局

Percent of participants achieving BP control, defined as <130/80 mmHg

时间窗: Month 6

The primary outcome will be the proportion of eligible patients at a practice site to achieve BP control (130/80 mmHg) at six months.

次要结局

  • Percent of participants achieving BP control, defined as <130/80 mmHg(Month 12)
  • Change from Baseline in hemoglobin A1c (HbA1c) levels at Month 6(Baseline, Month 6)
  • Change from Baseline in Systolic blood pressure (SBP) at Month 6(Baseline, Month 6)
  • Change from Baseline in Diastolic blood pressure (DBP) at Month 6(Baseline, Month 6)
  • Change from Baseline in DBP at Month 12(Baseline, Month 12)
  • Change from Baseline in HbA1c levels at Month 12(Baseline, Month 12)
  • Change from Baseline in SBP at Month 12(Baseline, Month 12)
  • Change from Baseline in Body mass index (BMI) at Month 6(Baseline, Month 6)
  • Change from Baseline in BMI at Month 12(Baseline, Month 12)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验